FundedIQ
Biotechnology

Evoralis: Funding, Investors & Team (Sep 2026)

Evoralis is a company focused on creating enzymes, specifically those that break down plastics, that originated from the University of Cambridge.

evoralis.com LinkedIn Cambridge, United Kingdom 1-10 employees
Biotechnology Recycling
Total raised
$3.3M
Rounds
1
Latest
Seed
Sep 2024

Evoralis has raised $3.3M across 1 funding round on record, the most recent a Seed of $3.3M announced in Sep 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Evoralis Company Profile and Key Stats

Total funding raised
$3.3M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$3.3M in Sep 2024
Employees
1-10
reported band
Headquarters
Cambridge, United Kingdom

Latest funding round on record: Sep 2024.

Evoralis Funding Rounds

Date
Round
Amount
Seed
$3.3M

Evoralis Founders and Leadership Team

Name
Role
Contact
Liisa Van Vliet
Founder
Locked

Contact details for the Evoralis team: 1 of 1 has an email address on file.

Start 14-day free trial →

Evoralis Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
5,285
$4.0M
16,575
$3.1M

Evoralis' latest round of $3.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Evoralis in Biotechnology and Cambridge

Companies Similar to Evoralis

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

IMU is a discovery engine mapping the immune system to advance precision medicine.

Series A $38.4M

Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…

Undisclosed round $5.4M

Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…

Undisclosed round

Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…

Pre-Seed $740k

Five is a biometric payment services company that offers thumb recognition technology for safe transactions.

Seed $6.0M

Evoralis Funding FAQs

What does Evoralis do?

Evoralis is a company focused on creating enzymes, specifically those that break down plastics, that originated from the University of Cambridge.

How much funding has Evoralis raised?

Evoralis has raised $3.3M across 1 round on record. The most recent is a Seed of $3.3M announced in Sep 2024.

When did Evoralis last raise funding?

Evoralis' most recent funding round on record is a Seed of $3.3M, announced in Sep 2024.

Who founded Evoralis?

FundedIQ lists Liisa Van Vliet (Founder) at Evoralis.

Where is Evoralis headquartered?

Evoralis is based in Cambridge, Cambridgeshire, United Kingdom.

How many employees does Evoralis have?

Evoralis is in the 1-10 employee band.

How does Evoralis' funding compare to other Biotechnology startups?

Evoralis' latest round of $3.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Evoralis Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evoralis is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.